Nitrite or sildenafil, but not BAY 41-2272, blunt acute pulmonary embolism-induced increases in circulating matrix metalloproteinase-9 and oxidative stress


Autoria(s): DIAS-JUNIOR, Carlos A.; CAU, Stefany B. A.; OLIVEIRA, Alisson M.; CASTRO, Michele M.; MONTENEGRO, Marcelo F.; GERLACH, Raquel F.; TANUS-SANTOS, Jose E.
Contribuinte(s)

UNIVERSIDADE DE SÃO PAULO

Data(s)

19/10/2012

19/10/2012

2009

Resumo

Introduction: Inhibition of matrix metalloproteinases (MMPs) improves the hemodynamics during acute pulmonary embolism (APE) and oxidative stress upregulates MMPs. We compared the effects of different NO-cGMP pathway activators on APE-induced increases in MMPs. Materials and Methods: Hemodynamic and biochemical evaluations were performed in non-embolized dogs treated with saline (N = 5), and in microspheres embolized dogs receiving saline (n = 9), or nitrite (6.75 mu mol/kg i.v. over 15 min followed by 0.28 mu mol/kg/min; n = 5), or sildenafil (0.25 mg/kg; n = 5), or BAY 41-2272 (0.03, 0.1, 0.3, and 1 mg/kg/h; n = 5). Plasma thiobarbituric acid reactive substances (TBARS) concentrations were determined. Zymograms of plasma samples were performed, and in vitro antioxidant effects or inhibition of MMPs by these drugs were examined. Results: APE increased mean pulmonary artery pressure by similar to 25 mmHg. Nitrite, BAY 41-2272, or sildenafil reversed this increase by similar to 40% (P < 0.05). Similar effects were seen on the pulmonary vascular resistance. While both nitrite and sildenafil produced no systemic effects, the highest dose of BAY 41-2272 produced systemic hypotension (P<0.05). While nitrite and sildenafil blunted the increases in plasma pro-MMP-9 levels and TBARS (all P < 0.05), BAY 41-2272 produced no such effects. Nitrite and sildenafll produced in vitro antioxidant effects and inhibited MMPs only at high concentrations. BAY 41-2272 produced no such effects. Conclusions: Activation of the NO-cGMP pathway with nitrite or sildenafil, but not with BAY 41-2272, attenuates APE-induced oxidative stress and increased MMP-9 levels. These findings are consistent with the idea that NO-cGMP pathway activators with antioxidant effects prevent the release of MMP-9 during APE. (c) 2008 Elsevier Ltd. All rights reserved.

Fundacao de Amparo A Pesquisa do Estado de Sao Paulo (FAPESP)

Conselho Nacional de Dsenvolvimento Cientifico e Tecnologico (CNPq)

Identificador

THROMBOSIS RESEARCH, v.124, n.3, p.349-355, 2009

0049-3848

http://producao.usp.br/handle/BDPI/24917

10.1016/j.thromres.2008.12.006

http://dx.doi.org/10.1016/j.thromres.2008.12.006

Idioma(s)

eng

Publicador

PERGAMON-ELSEVIER SCIENCE LTD

Relação

Thrombosis Research

Direitos

restrictedAccess

Copyright PERGAMON-ELSEVIER SCIENCE LTD

Palavras-Chave #Acute pulmonary embolism #BAY 41-2272 #Matrix metalloproteinases #Nitric oxide #Nitrite #Oxidative stress #Pulmonary hypertension #SMOOTH-MUSCLE-CELLS #MATRIX METALLOPROTEINASES #L-ARGININE #IMPROVES HEMODYNAMICS #CANINE MODEL #HYPERTENSION #OXIDE #THROMBOEMBOLISM #SUPEROXIDE #MMP-9 #Hematology #Peripheral Vascular Disease
Tipo

article

original article

publishedVersion